Ligand Pharmaceuticals Incorporated financial statements, including revenue, expenses, profit, and loss

The total revenue of LGND for the last quarter is 51.81 M USD, and it's 24.76% higher compared to the previous quarter. The net income of Q3 24 is -7.17 M USD.